Clearmind is a psychedelic medicine biotech company that focuses on the discovery and development of novel psychedelic derived therapeutics.
Clearmind Medicine has raised $7.3M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in September 2025.
Clearmind Medicine is headquartered in Vancouver, Canada.
Clearmind is a psychedelic medicine biotech company that focuses on the discovery and development of novel psychedelic derived therapeutics.
Clearmind Medicine is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clearmind Medicine — Funding & Investors." VCBacked, September 19, 2025, https://www.vcbacked.co/company/clearmind-medicine. Accessed August 15, 2026.
VCBacked. (2025). Clearmind Medicine — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/clearmind-medicine
{{cite web |title=Clearmind Medicine — Funding & Investors |url=https://www.vcbacked.co/company/clearmind-medicine |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated